Techno Medical PCLBKK:TM +1.08%74 ROE % is 7.46% as of Mar. 2026, which is 7% below its 10-year median of 8.06. GuruFocus rates BKK:TM with a GF Score™ of 74/100 and a GF Value™ of ฿1.20 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 115 Medical Distribution companies, Techno Medical PCL ranks worse than 51.3% on this metric.
The historical rank and industry rank for Techno Medical PCL's ROE % or its related term are showing as below:
BKK:TM'
s ROE % Range Over the Past 10 Years
Min: -5.47 Med: 8.06 Max: 14.17
Current: 7.09
During the past 11 years, Techno Medical PCL's highest ROE % was 14.17%. The lowest was -5.47%. And the median was 8.06%.
BKK:TM's ROE % is ranked worse than 51.3% of 115
companies
in the Medical Distribution industry
Industry Median: 7.1
vs BKK:TM: 7.09
Techno Medical PCL (BKK:TM) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Techno Medical PCL ROE % Related Terms
Techno Medical PCL ROE % Historical Data
* Premium members only.
The historical data trend for Techno Medical PCL's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Techno Medical PCL's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Techno Medical PCL ROE % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Techno Medical PCL's ROE % distribution charts can be found below:
* The bar in red indicates where Techno Medical PCL's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Techno Medical PCL (BKK:TM) has a ROE % of 7.46% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Techno Medical PCL and its competitors. This is near median its historical median of 8.06. According to the industry distribution chart, Techno Medical PCL ranks #59 out of 115 companies in the Medical Distribution industry, placing it in the top 51.3%.
Is Techno Medical PCL's ROE % too high?
Techno Medical PCL's current ROE % of 7.46% is near median its 10-year median of 8.06. The Medical Distribution industry median ROE % is 7.10. Techno Medical PCL's value of 7.46% is 5.1% above this industry median. Based on the distribution chart, Techno Medical PCL ranks #59 out of 115 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Techno Medical PCL has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Techno Medical PCL's ROE % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Techno Medical PCL ranks #59 out of 115 companies for ROE %. This places Techno Medical PCL in the lower half of its industry. The industry median ROE % is 7.10. Techno Medical PCL's value of 7.46% is 5.1% above this benchmark. While the company's 10-year median is 8.06 vs. the industry median of 7.10, Techno Medical PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Distribution company?
The median ROE % among Medical Distribution companies is 7.10, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Techno Medical PCL's current ROE % of 7.46% is 5.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Techno Medical PCL and its competitors. For the Medical Distribution industry, the median ROE % is 7.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Techno Medical PCL's current ROE % is 7.46%, which is near median its own 10-year median of 8.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Medical PCL stock overvalued right now?
Based on GuruFocus' analysis, Techno Medical PCL (BKK:TM) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.20, compared to a current price of ฿0.94 — trading 21.7% below its estimated fair value. The current ROE % is 7.46%, which is near median its 10-year median of 8.06 and 5.1% above the Medical Distribution industry median of 7.10. Techno Medical PCL's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Techno Medical PCL (BKK:TM), the current ROE % is 7.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Techno Medical PCL (BKK:TM) Overvalued in 2026?
Based on GuruFocus' analysis, Techno Medical PCL stock appears to be undervalued.
The current stock price of ฿0.94 is trading 21.7% below its estimated GF Value™ of ฿1.20.
GuruFocus considers Techno Medical PCL to be Modestly Undervalued.
Key valuation signals for BKK:TM:
ROE %: 7.46% (near median its 10-year median of 8.06)
GF Value™: ฿1.20 vs. price of ฿0.94 (21.7% below fair value)
Industry Position: 5.1% above the Medical Distribution median (#59 of 115)
No single metric tells the full story. See the BKK:TM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Techno Medical PCL is a Thailand-based company engaged in the trading business of medical supplies, tools, and equipment. The business activity of the group is import and distribution of operating instruments and disposable supplies, central sterile supply department products, instrument and supply used in laboratory and blood bank, and equipment and tools for heart surgery. Its segments consist of Disposable Equipment and Supplies, Sales of Medical Equipment and Instruments and Services related to Nursing Care. Maximum of revenue is Sales of Disposable Equipment and Supplies.
74GF Score
Get the complete analysis for BKK:TM
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:TM has been successfully added to your 
